unknown
Stage
About
Epicrispr Biotechnologies develops therapies that leverage epigenome modulation to dynamically control gene expression for treating complex diseases.
Explore Epicrispr Biotechnologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.